Advanced search
Publication Cover
Psoriasis: Targets and Therapy Volume 10, 2020 - Issue
Submit an article Journal homepage
102
Views
2
CrossRef citations to date
0
Altmetric
Case Report

CMV Infection: A Clinical Challenge in Biological Therapy? The Case of Asymptomatic Patients with Persistent Positive Immunoglobulin M Anti-CMV Treated with Secukinumab

Alessio Gambardella1 Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
,
Gaetano Licata1 Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, ItalyCorrespondence[email protected]
,
Giulia Calabrese1 Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
,
Alina De Rosa1 Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
,
Francesca Pagliuca2 Division of Pathology, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
,
Roberto Alfano3 Department of Anesthesiology, Surgery and Emergency, University of Campania Luigi Vanvitelli, Naples, Italy
&
Giuseppe Argenziano1 Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
 show all
Pages 57-60 | Published online: 27 Nov 2020

References

  • Petersen B, Lorentzen H. Cytomegalovirus complicating biological immunosuppressive therapy in two patients with psoriasis receiving treatment with etanercept or efalizumab. Acta Derm Venereol. 2008;88(5):523–524. doi:10.2340/00015555-049118779901
  • Miquel FJ, Colomina J, Marii JI, Ortega C. Cytomegalovirus infection in a patient treated with efalizumab for psoriasis. Arch Dermatol. 2009;145(8):961–962. doi:10.1001/archdermatol.2009.15419687445
  • Caudron A, Lok C, Clabaut A, Desblache J, Heyman B, Viseux V. Cytomegalovirus colitis in a patient treated with efalizumab. Dermatology. 2009;218(1):84–85. doi:10.1159/00017403819005243
  • Mencarini J, Spinicci M, Bartalesi F. Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter? Reumatismo. 2016;68(3):144–147. doi:10.4081/reumatismo.2016.89727981816
  • Krmpotić A, Podlech J, Reddehase MJ, Britt WJ, Jonjić S. Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades’ resume. Med Microbiol Immunol. 2019;208(3–4):415–429. doi:10.1007/s00430-019-00600-130923898
  • Sissons JG, Carmichael AJ. Clinical aspects and management of cytomegalovirus infection. J Infect. 2002;44(2):78–83. doi:10.1053/jinf.2001.094912076065
  • Vauloup-Fellous C, Lazzarotto T, Revello MG, Grangeot-Keros L. Clinical evaluation of the Roche Elecsys CMV IgG avidity assay. Eur J Clin Microbiol Infect Dis. 2014;33(8):1365–1369. doi:10.1007/s10096-014-2080-424584693
  • Ross SA, Novak Z, Pati S, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets. 2011;11(5):466–474. doi:10.2174/18715261179763670321827433
  • Bissonnette R, Luger T, Thaci D, et al. Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study). J Eur Acad Dermatol Venereol. 2018;32(9):1507–1514. doi:10.1111/jdv.1487829444376
  • Chiu HY, Chan CC, Tsai TF. The impact of long-term secukinumab treatment on Epstein-Barr virus and cytomegalovirus loads in patients with psoriasis. Int J Dermatol. 2016;55(11):e600–e602. doi:10.1111/ijd.1334627261186

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.